Project/Area Number |
25461376
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Metabolomics
|
Research Institution | Osaka City University |
Principal Investigator |
SHIOI ATSUSHI 大阪市立大学, 大学院医学研究科, 講師 (90260801)
|
Co-Investigator(Kenkyū-buntansha) |
SHOJI Tetsuo 大阪市立大学, 大学院医学研究科, 准教授 (40271192)
|
Project Period (FY) |
2013-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2015: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2014: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2013: ¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
|
Keywords | マクロファージ / HIF-1 / オンコスタチンM / LPS / 動脈硬化 / 血管石灰化 / オンコスタチンM / 血管平滑筋細胞 / 骨芽細胞 / JAK3 / STAT3 / HIF-1 / LPS |
Outline of Final Research Achievements |
We investigated the roles of hypoxia inducible factor 1 (HIF-1) in the development of atherosclerotic plaque calcification. In apoE-deficient mice, immunohistochemical staining revealed that macrophages are localized in hypoxic areas of atherosclerotic plaque lesions and that oncostatin M (OSM) is expressed in theses macrophages. Next, we investigated the stimulatory effects of OSM on osteoblastic differentiation of human vascular smooth muscle cells (HVSMC). OSM promoted osteoblastic differentiation of HVSMC through JAK3/STAT3 signaling pathway as evidenced by the experiments using specific inhibitor reagents and siRNAs. Finally, we examined the roles of HIF-1 in LPS-induced OSM expression in macrophages. The experiments utilizing inhibitors, hypoxia mimetics, and siRNA clarified that HIF-1 inhibits LPS-induced OSM expression in macrophages. These data suggest that HIF-1 in macrophages may play an inhibitory role in plaque calcification through inhibiting expression of OSM.
|